Abstract 1610: Development of meta-[211At]astatobenzylguanidine ([211At]MABG) as an alpha particle emitting systemic targeted radiotherapeutic for neuroblastoma

Published

Conference Paper

Full Text

Duke Authors

Cited Authors

  • Batra, V; Ranieri, P; Makvandi, M; Tsang, M; Hou, C; Li, Y; Vaidyanathan, G; Pryma, DA; Maris, JM

Published Date

  • August 1, 2015

Published In

  • Clinical Research (Excluding Clinical Trials)

Published By

Digital Object Identifier (DOI)

  • 10.1158/1538-7445.am2015-1610

Conference Name

  • Proceedings: AACR 106th Annual Meeting 2015; April 18-22, 2015; Philadelphia, PA